Gapping down
In reaction to earnings/guidance:
- DCT -1.7%
Other news:
- SGH -4% (stock offering)
- MAX -3% (CFO stepping down, reaffirms Q2 and FY21 guidance)
- QTNT -1.4% (stock offering)
- EVCM -1.1% (acquires Medical Design Tech)
- QGEN -0.7% (receives CE-IVD certification for NeuMoDx HAdV Quant Assay)
Analyst comments:
- LNT -0.7% (downgraded to Neutral from Buy at BofA Securities)
- CLDR -0.6% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)
- CLB -0.6% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)